U.S. Electric Utilities Stock News

XP (XP) is in focus after two product launches in Brazil: a partnership with prediction market platform Kalshi and the rollout of USDXP, a US$ backed stablecoin issued via Clear Corretora. See our latest analysis for XP. XP's recent product launches come after a mixed period for the share price. A 30 day share price return of an 8.4% decline contrasts with a 12.5% share price gain year to date and a 25.3% 1 year total shareholder return, suggesting momentum has softened in the short term...

Sotera Health recently completed a follow-on equity offering of US$381.75 million, issuing 25,000,000 common shares at US$15.27 each, boosting its capital base but increasing its share count. This fresh equity capital gives Sotera Health more financial flexibility to fund growth projects or reduce debt, while shareholders weigh the impact of dilution. Next, we'll examine how this sizeable equity raise and resulting dilution could reshape Sotera Health's investment narrative going...

Recent performance snapshot MetLife (MET) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. At a last close of $67.97 and annual revenue of about $77.1b against net income of roughly $3.2b, investors are weighing how this large US insurer’s fundamentals line up with the recent pullback. See our latest analysis for MetLife. MetLife’s recent 1 day share price...

In March 2026, Marsh announced that Nick Studer will become President and CEO of Marsh Risk on April 1, 2026, succeeding Martin South, who moves into an enterprise-wide role as Chief Client Officer while both remain on the Executive Committee reporting to John Doyle. This leadership reshuffle strengthens Marsh’s focus on client impact and innovation, bringing Oliver Wyman’s consulting expertise closer to the core risk business while a new Oliver Wyman CEO is named. Next, we’ll examine how...

In recent weeks, CCM Hockey and Mattel announced the launch of an all-new Barbie x CCM Collection of performance hockey gear and apparel aimed at making the sport more inclusive and expressive for a new generation of girls and athletes. This collaboration highlights Mattel’s broader push to extend the Barbie brand beyond traditional toys into sports and lifestyle, aligning with its ambition to build a wider entertainment and consumer-products platform. We’ll now look at how this inclusive...

Netflix, ticker NasdaqGS:NFLX, is cutting several dozen roles across its global product and creative studio teams. The move is part of a wider internal reorganization focused on marketing assets and live experience content. The restructuring affects how Netflix coordinates global marketing campaigns and manages cross team workflows. For you as an investor, this relates to how NasdaqGS:NFLX runs its core subscription and content business, not a single show or feature. The product and...

Warren Buffett’s Berkshire Hathaway has cut its stake in Bank of America (NYSE:BAC) by around 50% ahead of his retirement. The move reduces the influence of a long-standing, high profile shareholder that first invested in the bank in 2011. The reduction in holdings has been paired with a pivot toward other sectors in Berkshire’s portfolio. Bank of America is one of the largest US based banks, with a focus on consumer banking, wealth management, and corporate and investment services. The...

ORIC Pharmaceuticals (ORIC) came under pressure after Ipsen pulled cancer drug Tazverik over concerns about secondary hematologic malignancies, even though ORIC said its prostate cancer candidate rinzimetostat showed no malignancies in preclinical toxicity testing. See our latest analysis for ORIC Pharmaceuticals. At a share price of US$11.90, ORIC has seen a 19.12% 30 day share price return and 45.65% year to date. The 1 year total shareholder return of 52.76% and 3 year total shareholder...

Boeing (BA) is back in the spotlight after disclosing minor electrical wiring damage on undelivered 737 MAX jets, a quality issue that has weighed on the share price despite steady full year delivery guidance. See our latest analysis for Boeing. Those wiring disclosures have fed into recent share price weakness, with Boeing’s 7 day share price return of 9.18% and 30 day return of 13.61% standing in contrast to a 1 year total shareholder return of 29.71%. This suggests momentum has cooled in...

Simmons First National (NasdaqGS:SFNC) reported quarterly results that exceeded revenue and EPS expectations. The bank highlighted resilient operations and solid performance within its regional banking footprint. The update adds fresh information on the company’s current business momentum that has not been reflected in recent coverage. Simmons First National, trading at $18.61, has delivered a quarter that came in ahead of both revenue and earnings forecasts, which puts a fresh spotlight on...

Recent share performance context Ross Stores (ROST) has drawn investor attention after its shares delivered a 68.3% total return over the past year, along with a 12.9% gain year to date and a 12% return in the past 3 months. See our latest analysis for Ross Stores. At a share price of US$206.28, Ross Stores has recently eased back over the past week even after a solid 30 day share price return, while its 1 year total shareholder return of 68.3% and 3 year total shareholder return of 108.6%...

The Mosaic Company recently announced a quarterly dividend of US$0.2200 per share payable on June 2, 2026, while also advancing plans with Rainbow Rare Earths Ltd. to develop the Uberaba rare earths project in Brazil through new processing facilities targeting production by 2030. This move signals Mosaic’s effort to extract more value from its existing phosphate operations by recovering rare earth elements, potentially diversifying revenue beyond traditional fertilizers. Next, we’ll examine...

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...

In late 2025, Corcept Therapeutics received a Complete Response Letter from the FDA rejecting its New Drug Application for relacorilant on the grounds of insufficient evidence of effectiveness, prompting multiple securities class action lawsuits alleging the company misrepresented the drug’s regulatory prospects and prior FDA feedback. These lawsuits focus not just on the setback for relacorilant, but on claims that Corcept withheld repeated FDA concerns while continuing to promote the drug...

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...

The National Transportation Safety Board plans to hold a hearing on Ford Motor's BlueCruise hands free driving system following two fatal crashes. The hearing will examine how the advanced driver assistance system was used in the incidents and whether additional safety measures are needed. The review puts Ford's automated driving technology and safety practices under closer regulatory and public scrutiny. For investors watching NYSE:F at a current share price of $11.67, this hearing comes...

LKQ stock performance context LKQ (LKQ) shares closed at $29.34, with the stock showing a 1 day return of 1.38% and a 7 day decline of 6.77%. This sets the stage for a closer look at its recent performance. See our latest analysis for LKQ. At the current share price of $29.34, LKQ’s 30 day share price return of a 13.96% decline sits alongside a 1 year total shareholder return of a 26.95% decline, pointing to fading momentum rather than a short term blip. If LKQ’s recent pullback has you...

Earlier this month, AT&T announced over US$250.00 billion of planned U.S. connectivity investment through 2030, launched more flexible Unlimited Your Way wireless plans, and issued long-dated Canadian dollar bonds to support its network build-out. Together, these moves highlight AT&T’s push to reposition itself as a core connectivity platform for AI-era data demand while sharpening its consumer value proposition. Now we’ll examine how AT&T’s US$250.00 billion connectivity build-out plan...

Why Celldex Therapeutics (CLDX) is on investors’ radar today Celldex Therapeutics (CLDX) has drawn attention after recent trading, with shares last closing at $29.51 and showing mixed returns over the past week, month, past 3 months, and year. See our latest analysis for Celldex Therapeutics. Recent trading has been choppy, with a 30 day share price return of 28.30% and a 1 year total shareholder return of 44.52%, set against a weaker 3 year total shareholder return of 29.47% and a 5 year...

Recent share performance and business snapshot Titan America (TTAM) has drawn attention after a one month return showing a 16.1% decline, extending a past 3 months slide of 7.8%. This has prompted investors to reassess the cement and building materials producer. The Brussels based company reports annual revenue of US$1.65b and net income of US$178.46m, with recent revenue growth of 6.3% and net income growth of 13.7%. This has put a spotlight on how earnings support the current share...

G-III Apparel Group has reported a weaker fourth quarter for fiscal 2026, with sales falling to US$771.49 million and a net loss of US$31.94 million, while also guiding to lower near-term revenue and earnings as it exits Calvin Klein and Tommy Hilfiger licenses and absorbs charges related to the Saks Global bankruptcy. Alongside these softer results, the company reaffirmed its portfolio shift toward higher-margin owned brands, announced a US$0.10 quarterly dividend, and outlined a US$25...

PENN Entertainment (PENN) is back on investors’ radar after announcing a 203-room hotel tower and an expanded high-limit table games room at Hollywood Casino Columbus, both pending regulatory approvals. See our latest analysis for PENN Entertainment. Despite the hotel and high limit room expansion plans and the recent earnings surprise in Q4 2025, sentiment around PENN has been mixed. A 21.68% 1 month share price return contrasts with a 16.27% 1 year total shareholder return decline and an...